Psoriasis is associated with decreased adiponectin levels beyond cardiovascular and metabolic risk factors
R Li, P Krishnamoorthy, Y Yu, A Raper… - Endocrine …, 2012 - endocrine-abstracts.org
Methods: We prospectively enrolled a consecutive sample of patients with psoriasis (n= 122)
and compared cardiometabolic risk factors with an asymptomatic sample without psoriasis
from our practice (n= 129). Fasting lipids, insulin, glucose, and total plasma adiponectin
were measured by commercial assays. HOMA-IR was used to estimate IR. We performed
stepwise multivariable linear regression adjusting for CVD (age, gender, smoking status,
hypertension, lipids) and metabolic (HOMA-IR, waist size, triglycerides) risk factors using …
and compared cardiometabolic risk factors with an asymptomatic sample without psoriasis
from our practice (n= 129). Fasting lipids, insulin, glucose, and total plasma adiponectin
were measured by commercial assays. HOMA-IR was used to estimate IR. We performed
stepwise multivariable linear regression adjusting for CVD (age, gender, smoking status,
hypertension, lipids) and metabolic (HOMA-IR, waist size, triglycerides) risk factors using …